Evotec SE (EVO) Current Deferred Revenue (2020 - 2026)
Evotec SE's (EVO) quarterly Current Deferred Revenue came in at $154630.9 in Q1 2026, down 24.37% year-on-year from $204456.9 in Q1 2025, and down 8.59% quarter-over-quarter from $169163.5 in Q4 2025.
Evotec SE (EVO) Current Deferred Revenue (2020 - 2026) Analysis & Trends
Evotec SE has disclosed Current Deferred Revenue across 7 years of filings, most recently posting $154630.9 for Q1 2026.
- Current Deferred Revenue for Q1 2026 came in at $154630.9, down 24.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $154630.9 (down 24.37% YoY), and the FY2025 annual result was $169163.5, down 99.85% from the prior year.
- Current Deferred Revenue came in at $154630.9 for Q1 2026 at Evotec SE, down from $169163.5 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $125.4 million in Q4 2022 to a low of -$142951.5 in Q2 2022.
- The 5-year median for Current Deferred Revenue is $190800.6 (2025), against an average of $28.8 million.
- Across the five-year window, Current Deferred Revenue soared 153.44% in 2022 and plunged 99.85% in 2025, its largest moves.
- Evotec SE's Current Deferred Revenue stood at $125.4 million in 2022, then slipped by 16.28% to $105.0 million in 2023, then increased by 8.49% to $113.9 million in 2024, then slumped by 99.85% to $169163.5 in 2025, then dropped by 8.59% to $154630.9 in 2026.
- The last three Current Deferred Revenue figures came in at $154630.9 (Q1 2026), $169163.5 (Q4 2025), and $197969.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Evotec SE | 583.10 Mn | 582.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 154,630.91 |
| Dec 31, 2025 | 169,163.46 |
| Sep 30, 2025 | 197,968.96 |
| Jun 30, 2025 | 183,632.16 |
| Mar 31, 2025 | 204,456.88 |
| Dec 31, 2024 | 113.91 Mn |
| Sep 30, 2024 | 228,656.99 |
| Dec 31, 2023 | 105.00 Mn |
| Dec 31, 2022 | 125.41 Mn |
| Sep 30, 2022 | 181,458.12 |
| Jun 30, 2022 | -142,951.45 |
| Mar 31, 2022 | 126,672.65 |
| Dec 31, 2021 | 128.19 Mn |
| Sep 30, 2021 | 71,598.07 |
| Dec 31, 2020 | 79.26 Mn |